Preview Mode Links will not work in preview mode

Psound Bytes CME

Jul 16, 2020

Hear George Han, M.D. of the Icahn School of Medicine at Mt. Sinai, and Mark Kaufmann, M.D., President-Elect at the American Academy of Dermatology, discuss the new normal for dermatologists and learn about ILUMYA™ (tildrakizumab-asmn), a treatment for moderate-to-severe plaque psoriasis. This podcast episode is sponsored by Sun Pharma. For Important Safety Information:  For Full Prescribing Information: